Dr. J Paul Marcoux II, MD

  • Boston, MA
  • Hematologist and oncologist
NPI1790746907PAC ID3870587199
Medicare services, 2024
779
Medicare patients, 2024
291
Part D claims, 2024
556
Publications
9
MIPS score, 2024
84
Practice address
450 Brookline Avenue, Boston, MA 02115
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Dana-Farber Cancer Institute

Hospital · Boston, Massachusetts

See all 5 affiliations

Find Dr. Marcoux's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. J Paul Marcoux II is a hematologist and oncologist in Boston, Massachusetts

Dr. Marcoux practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.

Dr. Marcoux's NPI, 1790746907, was assigned on March 29, 2006. Dr. Marcoux graduated from University of Minnesota Medical School in 1987. Dr. Marcoux holds Massachusetts license 73616.

NPI and contact details
Medicare PAC ID
3870587199
NPI enumeration date
March 29, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
65
Medical school graduation
1987

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. J Paul Marcoux II practices at Dana-Farber Cancer Institute in Boston, Massachusetts

Dr. Marcoux's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.

Source: Dmand AI Affiliation Data

Dr. J Paul Marcoux II is affiliated with 4 sites of care and 1 medical group

Dr. Marcoux's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dr. Marcoux is also affiliated with Massachusetts General Hospital. The medical group on file is Binney Medical Group. Dmand AI also links Dr. Marcoux to 2 more hospitals, each named with a free account.

See all 5 affiliations for Dr. Marcoux

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. J Paul Marcoux II's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marcoux practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dana-Farber Cancer InstituteAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Marcoux practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.

Dr. J Paul Marcoux II is one of 429 hematologists and oncologists in Massachusetts

Hematology and oncology is Dr. Marcoux's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Marcoux is licensed in Massachusetts.

Specialties and state licenses

  • Hematology and oncology, MassachusettsPrimaryLicense 73616 · taxonomy 207RH0003X

Hematologists and oncologists near Dr. Marcoux

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. J Paul Marcoux II billed Medicare for 779 services in 2024

CMS data shows 779 Medicare services from Dr. Marcoux across 6 procedure codes in 2024, for 291 Medicare patients. Medicare paid $91,412 for them.

Medicare services, 2024779
Medicare patients291
Paid by Medicare$91,412
Procedure codes6

Dr. Marcoux's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6512024: 77920%

Where Dr. Marcoux's Medicare services took place, 2024

  • In an office75196%
  • In a facility284%

Dr. Marcoux compared with the Massachusetts median for hematologists and oncologists, 2024

  • Dr. Marcoux
  • Massachusetts median
Medicare services
779vs 49557% above
Medicare patients
291vs 20046% above
Part D claims
368vs 1512.4 times

Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.

Dr. Marcoux's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Marcoux

Need commercial claims for Dr. Marcoux?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Marcoux and other hematologists and oncologists in Massachusetts.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. J Paul Marcoux II treated 291 Medicare patients in 2024, average age 74

CMS counts 291 Medicare patients who saw Dr. Marcoux in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have cancer, and 73% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marcoux's median patient age at 73, with 61% women.

Medicare patients, 2024291
Average age74
Average risk score2.69
Also on Medicaid15%

Dr. Marcoux's Medicare patients by age, 2024

Dr. Marcoux's Medicare patients by sex, 2024

  • Women16055%
  • Men13145%

Chronic conditions among Dr. Marcoux's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol73%
  3. High blood pressure69%
  4. Arthritis46%
  5. COPD41%
  6. Anxiety34%
  7. Ischemic heart disease34%
  8. Chronic kidney disease29%

Share of Medicare patients with each condition. A patient can have several.

Dr. Marcoux's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women61%
  • Men38%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. J Paul Marcoux II wrote 556 Medicare Part D claims in 2024

In 2024, Dr. Marcoux wrote 556 Medicare Part D claims for 120 patients. 76% of them were for generic drugs. CMS names the drug for 368 of them, across 16 drugs with 11 or more claims each, at $1,880,822 in total drug cost. In 2023, CMS named 191 claims across 9 drugs.

Part D claims, 2024556
Drugs named by CMS16
Total drug cost$1.9M
Part D patients120

Dr. Marcoux's Part D claims by kind of drug, 2024

  • Generic420 claims76%
  • Brand-name136 claims24%

Dr. Marcoux's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Marcoux's Part D claims, 2024

  • Opioids6%35 of 556 claims
  • Antibiotics10%54 of 556 claims
  • Antipsychotics, patients 65 and over3%15 of 556 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1912024: 36893%

Drugs named by CMS: 16 in 2024, 9 in 2023.

See all prescribing by Dr. Marcoux

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. J Paul Marcoux II scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Marcoux for performance year 2024, reported as part of a group. Dr. Marcoux accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marcoux as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Marcoux's MIPS scores, performance year 2024

  • 84of 100Final score
  • 65of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 69of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Marcoux by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. J Paul Marcoux II has 9 publications on record

Dmand AI links 9 papers to Dr. Marcoux, published from 2011 to 2021. 2016 was the busiest year, with 2. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antineoplastic Agents. Dr. Marcoux's most frequent co-authors are Mark M. Awad, MD, PhD, David A. Barbie, MD and Rebecca Suk Heist, MD, MPH.

Papers9
Years published2011 to 2021

Dr. Marcoux's papers by year, 2011 to 2021

Topics Dr. Marcoux writes about most

  • Lung Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Antineoplastic Agents
  • Drug Resistance, Neoplasm
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • ErbB Receptors
  • Protein Kinase Inhibitors

Dr. Marcoux's most frequent co-authors

Recent publications by Dr. Marcoux

See all 9 publications and co-authors

See who Dr. Marcoux researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Marcoux works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. J Paul Marcoux II received $241 in industry payments from 2016 to 2025

CMS Open Payments shows 4 general payments to Dr. Marcoux from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. AstraZeneca Pharmaceuticals LP paid the most, $224. It also lists 1 research payment totaling $4,697 in 2020.

General payments to Dr. Marcoux by program year, 2016 to 2025

General payments to Dr. Marcoux by kind, 2016 to 2025

$241in total
  • Food and beverage$19882%
  • Education$4318%

Companies that paid Dr. Marcoux the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Marcoux

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. J Paul Marcoux II graduated from University of Minnesota Medical School

Dr. Marcoux graduated from University of Minnesota Medical School in 1987.

  1. Medical schoolUniversity of Minnesota Medical School

Source: Dmand AI Professional Profile Data

Sources for Dr. J Paul Marcoux II's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. J Paul Marcoux II

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. J Paul Marcoux II's NPI number?

Dr. J Paul Marcoux II's NPI number is 1790746907. It was assigned on March 29, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. J Paul Marcoux II?

Dr. J Paul Marcoux II is a hematologist and oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. J Paul Marcoux II practice?

Dr. Marcoux practices at 450 Brookline Avenue, Boston, MA 02115. Dr. Marcoux's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dmand AI also links Dr. Marcoux to 2 hospitals.

What is Dr. J Paul Marcoux II's medical license number?

Dr. Marcoux holds Massachusetts license 73616.

Which hospitals is Dr. J Paul Marcoux II affiliated with?

Dr. Marcoux practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Marcoux is also affiliated with Massachusetts General Hospital. Dmand AI links Dr. Marcoux to 2 more hospitals.

What medical group is Dr. J Paul Marcoux II part of?

Dr. Marcoux is linked to Binney Medical Group.

Does Dr. J Paul Marcoux II accept Medicare?

Yes. CMS data shows Dr. Marcoux billed Medicare for 779 services in 2024, and Dr. Marcoux accepts Medicare assignment.

Does Dr. J Paul Marcoux II offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Marcoux as offering telehealth services.

What is Dr. J Paul Marcoux II's MIPS score?

Dr. Marcoux's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

How many Medicare patients does Dr. J Paul Marcoux II see?

CMS counts 291 Medicare patients who saw Dr. Marcoux in 2024, with an average age of 74.

Show 7 more questionsShow fewer questions

What services does Dr. J Paul Marcoux II bill to Medicare?

In 2024, Dr. Marcoux's most billed Medicare services were office visit, established patient (99215), office visit, new patient (99205) and office visit, established patient (99214).

Where did Dr. J Paul Marcoux II go to medical school?

Dr. Marcoux graduated from University of Minnesota Medical School in 1987.

What drugs does Dr. J Paul Marcoux II prescribe most?

In 2024 Medicare Part D data, Dr. Marcoux's most prescribed drugs by claims were Gabapentin, Tagrisso and Dexamethasone.

Has Dr. J Paul Marcoux II received payments from drug or device companies?

CMS Open Payments shows $241 in general payments to Dr. Marcoux from 2 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. J Paul Marcoux II been practicing?

Dr. Marcoux graduated from medical school in 1987, 39 years ago.

Does Dr. J Paul Marcoux II do research?

Dmand AI links 9 publications to Dr. Marcoux, published from 2011 to 2021.

Who does Dr. J Paul Marcoux II publish with?

Dr. Marcoux's most frequent co-authors are Mark M. Awad, MD, PhD (2 shared papers), David A. Barbie, MD (2 shared papers) and Rebecca Suk Heist, MD, MPH (2 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)